Company Analysis
Sign in

IM Cannabis Corp. (IMCC)

Nasdaq: IMCC · Medicinal Chemicals & Botanical Products · Central District, IL · filing with the SEC since 2019
Full chart Alerts Compare
Grade4.8
◀ Past 6.4● Present 4.3▶ Future 3.7
2 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart
The companyfiscal 2025, as filed
RevenueC$54.7M+1.3%
Net income-C$11.8M+0.2%
Earnings per sharen/a
Operating cash flowC$4.7M+537.9%
CashC$2.7M+216.0%
DebtC$15.3M-2.2%
Shareholders’ equity-C$3.6M-214.9%
Shares, dilutedn/a
Return on equityn/a
The recordfrom its filings
Filings in 202642
Newest filingNov 10 · F-3
Annual reportMar 30, 2026
Quarterly reportn/a
Next report due20-F by Apr 30
Insider sales, 12 months$0.00
Insider buys, 12 months$0.00
Patents grantedn/a
Filer categoryNon-accelerated filer<br>Emerging growth company
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
19202122232425
As filed, in CAD. Nothing here is a forecast.

News

Oct 20, 2026 · SEC EDGAR · Form EFFECT
Registration effective
Open the filing on sec.gov
Sep 30, 2026 · SEC EDGAR · Form SCHEDULE 13G
Large holder notice
Open the filing on sec.gov
Sep 30, 2026 · SEC EDGAR · Form SCHEDULE 13G
Large holder notice
Open the filing on sec.gov
Sep 30, 2026 · SEC EDGAR · Form SCHEDULE 13G
Large holder notice
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton IMCC · research, not advice